
August 24, 2022
Silo Wellness (CSE:SILO, OTCQB:SILFF) is pursuing two parallel tracks to capitalize on the growing market fully. First, biotech research represents its long-term track, with the second track focusing on providing services in jurisdictions where legal barriers have been removed. The company, which was founded in Oregon by an Oregon lawyer, has previously launched Oregon’s first legal psychedelic retreats via ketamine (also a U.S. legal first).
Silo Wellness is pursuing treatment programs in Oregon under Ballot Measure 109, and has a proof of concept center in Jamaica. Combined, the company has a unique combination of business lines for both near-term and long-term revenue.

Company Highlights
- Silo Wellness is a psychedelic wellness company with a parallel track focusing on developing wellness facilities and a psilocybin- or derivative-based treatment.
- Silo Wellness is the only publicly traded company with an operational foothold in Oregon that replicates its proof of concept for psilocybin in Jamaica.
- The company’s Jamaican psychedelic wellness retreats provide a current revenue stream.
- With the pending acquisition of Dyscovry Science the company intends to develop novel psilocybin treatments in addition to its psychedelic wellness facilities.
- An experienced team of managers and scientists lead the company towards its goals of widespread treatment with psilocybin-based treatments.
This Silo Wellness profile is part of a paid investor education campaign.*
Click here to connect with Silo Wellness (CSE:SILO, OTCQB:SILFF) to receive an Investor Presentation
SILO:CNX

Sign up to get your FREE
Born Defense Investor Kit
and hear about exciting investment opportunities.
- Corporate info
- Insights
- Growth strategies
- Upcoming projects
GET YOUR FREE INVESTOR KIT
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.
The Conversation (0)
23 August 2022
Born Defense
Psychedelic Healing Right Now & Pharmaceutical Biotech
Psychedelic Healing Right Now & Pharmaceutical Biotech Keep Reading...
30 October
Appendix 4C Cashflow Statementand Quarterly Activities Report
The Calmer Co. International Limited (ASX: CCO) submits the following Activities Report and Appendix 4C Cash Flow Statement for the three-month period ended 30th September 2026. Highlights Record quarterly revenue of $2.44 million, up 42% on the prior quarter, driven by wholesale and B2B sales... Keep Reading...
07 October
Coles Orders Fiji Kava® FZZR™ – First Flavoured Kava Product to Launch in Australia
The Calmer Co. International Limited (ASX: CCO), a leading consumer packaged goods company specialising in kava and other natural products that promote relaxation and sleep support, refers to its ASX announcement of 24 June 2026 and is pleased to advise that Coles has placed its initial order... Keep Reading...
28 August
Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2025 Results and Provides Corporate Update
Q4 Fiscal 2025 Highlights Revenue of $2.3 million, a 29.0% increase over Q3 2025 Gross profit of $1.4 million, compared to a gross profit of $0.8 million in Q3 2025 Cash position of $0.5 million as of August 31, 2025 Subsequent to Quarter End On April 18, 2026, President Donald Trump signed an... Keep Reading...
17 August
The Calmer Co. Secures Exclusive Global Distribution Agreement for Kava Extract Ingredients up to $25 million
Brisbane, Australia - The Calmer Co. International Limited (ASX: CCO), a leading consumer packaged goods company specialising in kava and other natural products that promote relaxation and sleep support, is pleased to announce the execution of an Exclusive Distribution Agreement with a... Keep Reading...
29 July
Psychedelics Market Trends: H1 2026 Review and Forecast
The psychedelic medicine market is moving swiftly from speculative research mode toward an institutional, prescription-oriented framework as federal policy in the US becomes more supportive.President Donald Trump’s April 18 executive order on ibogaine and other psychedelic therapies helped... Keep Reading...
Latest News

Sign up to get your FREE
Born Defense Investor Kit
and hear about exciting investment opportunities.
- Corporate info
- Insights
- Growth strategies
- Upcoming projects
GET YOUR FREE INVESTOR KIT
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00






